ARCHIVES

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

This article is from The Cancer Letter archive.

Vol. 18 No. 29 | July 17, 1992

Download PDF Visit The Full Archive

Related Articles

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986